Testing effectiveness (Phase 2)Study completedNCT05145283
What this trial is testing
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation
Who this might be right for
Acute Ischemic StrokeAcute Renal Injury
University Hospital, Basel, Switzerland 141